ID   PLCB1_MOUSE             Reviewed;        1216 AA.
AC   Q9Z1B3; Q62075; Q6PDH1; Q8K5A5; Q8K5A6; Q9Z0E5; Q9Z2T5;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   07-APR-2021, entry version 187.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 {ECO:0000305};
DE            EC=3.1.4.11 {ECO:0000250|UniProtKB:Q9NQ66};
DE   AltName: Full=PLC-154;
DE   AltName: Full=Phosphoinositide phospholipase C-beta-1;
DE   AltName: Full=Phospholipase C-beta-1;
DE            Short=PLC-beta-1;
GN   Name=Plcb1 {ECO:0000312|MGI:MGI:97613}; Synonyms=Plcb;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RC   STRAIN=SWR/J;
RA   Bai J., Wu K., Marks D.L., Machamer C., Pagano R.E.;
RT   "Cloning of PI-specific phospholipase C's from 3T3 cells. Expression and
RT   membrane targeting of a novel phospholipase C-beta-1 isoform.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
RC   STRAIN=ILS, and ISS;
RX   PubMed=11471062; DOI=10.1007/s00335-001-1001-x;
RA   Ehringer M.A., Thompson J., Conroy O., Xu Y., Yang F., Canniff J.,
RA   Beeson M., Gordon L., Bennett B., Johnson T.E., Sikela J.M.;
RT   "High-throughput sequence identification of gene coding variants within
RT   alcohol-related QTLs.";
RL   Mamm. Genome 12:657-663(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-145.
RC   STRAIN=C57BL/6J;
RX   PubMed=9753089; DOI=10.1046/j.1460-9568.1998.00213.x;
RA   Watanabe M., Nakamura M., Sato K., Kano M., Simon M.I., Inoue Y.;
RT   "Patterns of expression for the mRNA corresponding to the four isoforms of
RT   phospholipase Cbeta in mouse brain.";
RL   Eur. J. Neurosci. 10:2016-2025(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 428-615.
RC   TISSUE=Oocyte;
RX   PubMed=8687404; DOI=10.1042/bj3160583;
RA   Dupont G., McGuinness O.M., Johnson M.H., Berridge M.J., Borgese F.;
RT   "Phospholipase C in mouse oocytes: characterization of beta and gamma
RT   isoforms and their possible involvement in sperm-induced Ca2+ spiking.";
RL   Biochem. J. 316:583-591(1996).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18802028; DOI=10.1161/circresaha.108.176024;
RA   Wright C.D., Chen Q., Baye N.L., Huang Y., Healy C.L., Kasinathan S.,
RA   O'Connell T.D.;
RT   "Nuclear alpha1-adrenergic receptors signal activated ERK localization to
RT   caveolae in adult cardiac myocytes.";
RL   Circ. Res. 103:992-1000(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236; SER-417; THR-509;
RP   SER-511; SER-582; SER-978; SER-987; SER-1197; SER-1199 AND SER-1200, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, and Pancreas;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   FUNCTION, AND PALMITOYLATION AT CYS-17 BY ZDHHC21.
RX   PubMed=27653213; DOI=10.1038/ncomms12823;
RA   Beard R.S. Jr., Yang X., Meegan J.E., Overstreet J.W., Yang C.G.,
RA   Elliott J.A., Reynolds J.J., Cha B.J., Pivetti C.D., Mitchell D.A.,
RA   Wu M.H., Deschenes R.J., Yuan S.Y.;
RT   "Palmitoyl acyltransferase DHHC21 mediates endothelial dysfunction in
RT   systemic inflammatory response syndrome.";
RL   Nat. Commun. 7:12823-12823(2016).
CC   -!- FUNCTION: Catalyzes the hydrolysis of 1-phosphatidylinositol 4,5-
CC       bisphosphate into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate
CC       (IP3) and mediates intracellular signaling downstream of G protein-
CC       coupled receptors (PubMed:27653213). Regulates the function of the
CC       endothelial barrier (PubMed:27653213). {ECO:0000269|PubMed:27653213,
CC       ECO:0000303|PubMed:27653213}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-
CC         diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456,
CC         ChEBI:CHEBI:203600; EC=3.1.4.11;
CC         Evidence={ECO:0000250|UniProtKB:Q9NQ66};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33180;
CC         Evidence={ECO:0000250|UniProtKB:Q9NQ66};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O =
CC         1D-myo-inositol 1-phosphate + a 1,2-diacyl-sn-glycerol + H(+);
CC         Xref=Rhea:RHEA:43484, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:57880, ChEBI:CHEBI:58433;
CC         Evidence={ECO:0000250|UniProtKB:P10687};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43485;
CC         Evidence={ECO:0000250|UniProtKB:P10687};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with DGKQ. {ECO:0000250|UniProtKB:Q9NQ66}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000269|PubMed:18802028}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P10687}. Note=Colocalizes with the
CC       adrenergic receptors, ADREN1A and ADREN1B, at the nuclear membrane of
CC       cardiac myocytes. {ECO:0000269|PubMed:18802028}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A; Synonyms=C-beta-1a;
CC         IsoId=Q9Z1B3-1; Sequence=Displayed;
CC       Name=B; Synonyms=C-beta-1b;
CC         IsoId=Q9Z1B3-2; Sequence=VSP_008917;
CC       Name=C;
CC         IsoId=Q9Z1B3-3; Sequence=VSP_008918;
CC   -!- PTM: Palmitoylated (PubMed:27653213). Palmitoylation at Cys-17 by
CC       ZDHHC21 regulates the signaling activity of PLCB1 and the function of
CC       the endothelial barrier (Probable). Palmitoylation by ZDHHC21 is
CC       stimulated by inflammation (PubMed:27653213).
CC       {ECO:0000269|PubMed:27653213, ECO:0000305|PubMed:27653213}.
CC   -!- MISCELLANEOUS: The receptor-mediated activation of PLC-beta-1 is
CC       mediated by two G-protein alpha subunits, alpha-Q and alpha-11.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U85712; AAD00571.1; -; mRNA.
DR   EMBL; U85713; AAD00572.1; -; mRNA.
DR   EMBL; U85714; AAD00573.1; -; mRNA.
DR   EMBL; AF498249; AAM22966.1; -; mRNA.
DR   EMBL; AF498250; AAM22967.1; -; mRNA.
DR   EMBL; AL840635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL928635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL928956; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL935278; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC058710; AAH58710.1; -; mRNA.
DR   EMBL; AF022801; AAD01749.1; -; mRNA.
DR   EMBL; X95344; CAA64637.1; -; mRNA.
DR   CCDS; CCDS16787.1; -. [Q9Z1B3-2]
DR   CCDS; CCDS50729.1; -. [Q9Z1B3-1]
DR   PIR; S68256; S68256.
DR   RefSeq; NP_001139302.1; NM_001145830.1. [Q9Z1B3-1]
DR   RefSeq; NP_062651.2; NM_019677.2. [Q9Z1B3-2]
DR   SMR; Q9Z1B3; -.
DR   BioGRID; 202232; 10.
DR   IntAct; Q9Z1B3; 6.
DR   MINT; Q9Z1B3; -.
DR   STRING; 10090.ENSMUSP00000105743; -.
DR   iPTMnet; Q9Z1B3; -.
DR   PhosphoSitePlus; Q9Z1B3; -.
DR   SwissPalm; Q9Z1B3; -.
DR   PaxDb; Q9Z1B3; -.
DR   PeptideAtlas; Q9Z1B3; -.
DR   PRIDE; Q9Z1B3; -.
DR   ProteomicsDB; 289918; -. [Q9Z1B3-1]
DR   ProteomicsDB; 289919; -. [Q9Z1B3-2]
DR   ProteomicsDB; 289920; -. [Q9Z1B3-3]
DR   Antibodypedia; 3795; 267 antibodies.
DR   Ensembl; ENSMUST00000070724; ENSMUSP00000064844; ENSMUSG00000051177. [Q9Z1B3-2]
DR   Ensembl; ENSMUST00000110116; ENSMUSP00000105743; ENSMUSG00000051177. [Q9Z1B3-1]
DR   Ensembl; ENSMUST00000131552; ENSMUSP00000118756; ENSMUSG00000051177. [Q9Z1B3-2]
DR   GeneID; 18795; -.
DR   KEGG; mmu:18795; -.
DR   UCSC; uc008mnx.2; mouse. [Q9Z1B3-2]
DR   UCSC; uc008mny.2; mouse. [Q9Z1B3-1]
DR   CTD; 23236; -.
DR   MGI; MGI:97613; Plcb1.
DR   eggNOG; KOG1265; Eukaryota.
DR   GeneTree; ENSGT00940000155428; -.
DR   InParanoid; Q9Z1B3; -.
DR   OMA; RDIAQIW; -.
DR   TreeFam; TF313216; -.
DR   BRENDA; 3.1.4.11; 3474.
DR   Reactome; R-MMU-112043; PLC beta mediated events.
DR   Reactome; R-MMU-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-MMU-399997; Acetylcholine regulates insulin secretion.
DR   Reactome; R-MMU-4086398; Ca2+ pathway.
DR   Reactome; R-MMU-416476; G alpha (q) signalling events.
DR   Reactome; R-MMU-418217; G beta:gamma signalling through PLC beta.
DR   Reactome; R-MMU-434316; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion.
DR   Reactome; R-MMU-500657; Presynaptic function of Kainate receptors.
DR   BioGRID-ORCS; 18795; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Plcb1; mouse.
DR   PRO; PR:Q9Z1B3; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q9Z1B3; protein.
DR   Bgee; ENSMUSG00000051177; Expressed in dorsal striatum and 303 other tissues.
DR   ExpressionAtlas; Q9Z1B3; baseline and differential.
DR   Genevisible; Q9Z1B3; MM.
DR   GO; GO:0000785; C:chromatin; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0098982; C:GABA-ergic synapse; IMP:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005509; F:calcium ion binding; ISO:MGI.
DR   GO; GO:0005516; F:calmodulin binding; ISS:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; ISS:BHF-UCL.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISS:BHF-UCL.
DR   GO; GO:0005521; F:lamin binding; IPI:BHF-UCL.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:BHF-UCL.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:BHF-UCL.
DR   GO; GO:0060466; P:activation of meiosis involved in egg activation; IDA:BHF-UCL.
DR   GO; GO:0007420; P:brain development; NAS:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; IC:BHF-UCL.
DR   GO; GO:1902618; P:cellular response to fluoride; ISO:MGI.
DR   GO; GO:1905631; P:cellular response to glyceraldehyde; ISO:MGI.
DR   GO; GO:1904637; P:cellular response to ionomycin; ISO:MGI.
DR   GO; GO:1904117; P:cellular response to vasopressin; ISO:MGI.
DR   GO; GO:0021987; P:cerebral cortex development; IMP:BHF-UCL.
DR   GO; GO:0030218; P:erythrocyte differentiation; TAS:BHF-UCL.
DR   GO; GO:0045444; P:fat cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0007213; P:G protein-coupled acetylcholine receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0032957; P:inositol trisphosphate metabolic process; ISO:MGI.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; ISO:MGI.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0035723; P:interleukin-15-mediated signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0030225; P:macrophage differentiation; NAS:BHF-UCL.
DR   GO; GO:0007613; P:memory; IMP:BHF-UCL.
DR   GO; GO:0006397; P:mRNA processing; TAS:BHF-UCL.
DR   GO; GO:2000438; P:negative regulation of monocyte extravasation; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0001556; P:oocyte maturation; NAS:BHF-UCL.
DR   GO; GO:0031161; P:phosphatidylinositol catabolic process; ISO:MGI.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; ISS:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IBA:GO_Central.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; IMP:BHF-UCL.
DR   GO; GO:2000560; P:positive regulation of CD24 production; IDA:BHF-UCL.
DR   GO; GO:0048639; P:positive regulation of developmental growth; IMP:BHF-UCL.
DR   GO; GO:0040019; P:positive regulation of embryonic development; IMP:BHF-UCL.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IMP:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISS:BHF-UCL.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IDA:BHF-UCL.
DR   GO; GO:0032417; P:positive regulation of sodium:proton antiporter activity; NAS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:1903140; P:regulation of establishment of endothelial barrier; IMP:UniProtKB.
DR   GO; GO:0080154; P:regulation of fertilization; IMP:BHF-UCL.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0099178; P:regulation of retrograde trans-synaptic signaling by endocanabinoid; IMP:SynGO.
DR   GO; GO:0034284; P:response to monosaccharide; ISO:MGI.
DR   GO; GO:0043434; P:response to peptide hormone; ISO:MGI.
DR   GO; GO:0007165; P:signal transduction; TAS:BHF-UCL.
DR   CDD; cd13361; PH_PLC_beta; 1.
DR   Gene3D; 1.20.1230.10; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR016280; PLC-beta.
DR   InterPro; IPR028400; PLC-beta1.
DR   InterPro; IPR014815; PLC-beta_C.
DR   InterPro; IPR042531; PLC-beta_C_sf.
DR   InterPro; IPR009535; PLC-beta_CS.
DR   InterPro; IPR037862; PLC-beta_PH.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF12; PTHR10336:SF12; 1.
DR   Pfam; PF06631; DUF1154; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF17787; PH_14; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   Pfam; PF08703; PLC-beta_C; 1.
DR   PIRSF; PIRSF000956; PLC-beta; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cytoplasm; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Lipoprotein; Membrane; Nucleus; Palmitate;
KW   Phosphoprotein; Reference proteome; Transducer.
FT   CHAIN           1..1216
FT                   /note="1-phosphatidylinositol 4,5-bisphosphate
FT                   phosphodiesterase beta-1"
FT                   /id="PRO_0000088487"
FT   DOMAIN          316..467
FT                   /note="PI-PLC X-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   DOMAIN          540..656
FT                   /note="PI-PLC Y-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00271"
FT   DOMAIN          656..786
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   COMPBIAS        914..1088
FT                   /note="Lys-rich"
FT   ACT_SITE        331
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   ACT_SITE        378
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   MOD_RES         236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         509
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         887
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P10894"
FT   MOD_RES         978
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         987
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   LIPID           17
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:27653213"
FT   VAR_SEQ         1142..1216
FT                   /note="LQTELEQEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGSAPPSLASDAAKV
FT                   NLKSPSSEEIERENPGREFDTPL -> GEGPSSVLSEGCHEDPSVPPNFTPPNPQALKW
FT                   (in isoform B)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_008917"
FT   VAR_SEQ         1199..1216
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:11471062"
FT                   /id="VSP_008918"
FT   CONFLICT        28
FT                   /note="F -> L (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        41
FT                   /note="I -> T (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67
FT                   /note="S -> T (in Ref. 5; AAD01749)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        79
FT                   /note="K -> E (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="V -> A (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        561
FT                   /note="R -> I (in Ref. 6; CAA64637)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        613
FT                   /note="L -> I (in Ref. 6; CAA64637)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        622
FT                   /note="V -> M (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        714
FT                   /note="K -> T (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        795
FT                   /note="V -> D (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        923
FT                   /note="Q -> H (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        957
FT                   /note="N -> I (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1084
FT                   /note="K -> T (in Ref. 1; AAD00571/AAD00572/AAD00573)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1216 AA;  138396 MW;  CC751D49895A47D0 CRC64;
     MAGAQPGVHA LQLKPVCVSD SLKKGTKFVK WDDDSTIVTP IILRTDPQGF FFYWTDQNKE
     TELLDLSLVK DARCGKHAKA PKDPKLRELL DVGNIGHLEQ RMITVVYGPD LVNISHLNLV
     AFQEEVAKEW TNEVFSLATN LLAQNMSRDA FLEKAYTKLK LQVTPEGRIP LKNIYRLFSA
     DRKRVETALE ACSLPSSRND SIPQEDFTPD VYRVFLNNLC PRPEIDNIFS EFGAKSKPYL
     TVDQMMDFIN LKQRDPRLNE ILYPPLKQEQ VQVLIEKYEP NSSLAKKGQM SVDGFMRYLS
     GEENGVVSPE KLDLNEDMSQ PLSHYFINSS HNTYLTAGQL AGNSSVEMYR QVLLSGCRCV
     ELDCWKGRTA EEEPVITHGF TMTTEISFKE VIEAIAECAF KTSPFPILLS FENHVDSPKQ
     QAKMAEYCRL IFGDALLMEP LEKYPLESGV PLPSPMDLMY KILVKNKKKS HKSSEGSGKK
     KLSEQASNTY SDSSSVFEPS SPGAGEADTE SDDDDDDDDC KKSSMDEGTA GSEAMATEEM
     SNLVNYIQPV KFESFEISKK RNKSFEMSSF VETKGLEQLT KSPVEFVEYN KMQLSRIYPK
     GTRVDSSNYM PQLFWNAGCQ MVALNFQTVD LAMQINMGMY EYNGKSGYRL KPEFMRRPDK
     HFDPFTEGIV DGIVANTLSV KIISGQFLSD KKVGTYVEVD MFGLPVDTRR KAFKTKTSQG
     NAVNPVWEEE PIVFKKVVLP SLACLRIAAY EEGGKFIGHR ILPVQAIRPG YHYICLRNER
     NQPLTLPAVF VYIEVKDYVP DTYADVIEAL SNPIRYVNLM EQRAKQLAAL TLEDEEEVKK
     EADPGETSSE APSETRTTPA ENGVNHTASL APKPPSQAPH SQPAPGSVKA PAKTEDLIQS
     VLTEVEAQTI EELKQQKSFV KLQKKHYKEM KDLVKRHHKK TTELIKEHTT KYNEIQNDYL
     RRRAALEKSA KKDSKKKSEP SSPDHGSSAI EQDLAALDAE MTQKLIDLKD KQQQQLLNLR
     QEQYYSEKYQ KREHIKLLIQ KLTDVAEECQ NNQLKKLKEI CEKEKKELKK KMDKKRQEKI
     TEAKSKDKSQ MEEEKTEMIR SYIQEVVQYI KRLEEAQSKR QEKLVEKHNE IRQQILDEKP
     KLQTELEQEY QDKFKRLPLE ILEFVQEAMK GKISEDSNHG SAPPSLASDA AKVNLKSPSS
     EEIERENPGR EFDTPL
//
